India Specifies Requirements For Pharmacovigilance System Master File, Qualified Person
Executive Summary
The Indian government has borrowed some EU concepts while framing a pharmacovigilance guideline for marketing authorization holders. The guideline, effective January 2018, requires marketing authorization holders to maintain a pharmacovigilance system master file within India where the main pharmacovigilance activities take place, and to hire a pharmacovigilance qualified person to oversee the entire system.
You may also be interested in...
Four-Year Cycle For Routine Pharmacovigilance Inspections On Cards In India
New procedures for planning and scheduling routine pharmacovigilance inspections in India are based on a 2009 EU guideline.
Industry criticizes India's reliance on drug importers for ADR-related action
India has underscored the significance of proactive reporting by drug importers of adverse reaction-related "administrative action" of foreign regulators as part of the country's efforts to improve regulatory compliance1.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.